Cargando…
Network controllability solutions for computational drug repurposing using genetic algorithms
Control theory has seen recently impactful applications in network science, especially in connections with applications in network medicine. A key topic of research is that of finding minimal external interventions that offer control over the dynamics of a given network, a problem known as network c...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791995/ https://www.ncbi.nlm.nih.gov/pubmed/35082323 http://dx.doi.org/10.1038/s41598-022-05335-3 |
_version_ | 1784640309765865472 |
---|---|
author | Popescu, Victor-Bogdan Kanhaiya, Krishna Năstac, Dumitru Iulian Czeizler, Eugen Petre, Ion |
author_facet | Popescu, Victor-Bogdan Kanhaiya, Krishna Năstac, Dumitru Iulian Czeizler, Eugen Petre, Ion |
author_sort | Popescu, Victor-Bogdan |
collection | PubMed |
description | Control theory has seen recently impactful applications in network science, especially in connections with applications in network medicine. A key topic of research is that of finding minimal external interventions that offer control over the dynamics of a given network, a problem known as network controllability. We propose in this article a new solution for this problem based on genetic algorithms. We tailor our solution for applications in computational drug repurposing, seeking to maximize its use of FDA-approved drug targets in a given disease-specific protein-protein interaction network. We demonstrate our algorithm on several cancer networks and on several random networks with their edges distributed according to the Erdős–Rényi, the Scale-Free, and the Small World properties. Overall, we show that our new algorithm is more efficient in identifying relevant drug targets in a disease network, advancing the computational solutions needed for new therapeutic and drug repurposing approaches. |
format | Online Article Text |
id | pubmed-8791995 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-87919952022-01-27 Network controllability solutions for computational drug repurposing using genetic algorithms Popescu, Victor-Bogdan Kanhaiya, Krishna Năstac, Dumitru Iulian Czeizler, Eugen Petre, Ion Sci Rep Article Control theory has seen recently impactful applications in network science, especially in connections with applications in network medicine. A key topic of research is that of finding minimal external interventions that offer control over the dynamics of a given network, a problem known as network controllability. We propose in this article a new solution for this problem based on genetic algorithms. We tailor our solution for applications in computational drug repurposing, seeking to maximize its use of FDA-approved drug targets in a given disease-specific protein-protein interaction network. We demonstrate our algorithm on several cancer networks and on several random networks with their edges distributed according to the Erdős–Rényi, the Scale-Free, and the Small World properties. Overall, we show that our new algorithm is more efficient in identifying relevant drug targets in a disease network, advancing the computational solutions needed for new therapeutic and drug repurposing approaches. Nature Publishing Group UK 2022-01-26 /pmc/articles/PMC8791995/ /pubmed/35082323 http://dx.doi.org/10.1038/s41598-022-05335-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Popescu, Victor-Bogdan Kanhaiya, Krishna Năstac, Dumitru Iulian Czeizler, Eugen Petre, Ion Network controllability solutions for computational drug repurposing using genetic algorithms |
title | Network controllability solutions for computational drug repurposing using genetic algorithms |
title_full | Network controllability solutions for computational drug repurposing using genetic algorithms |
title_fullStr | Network controllability solutions for computational drug repurposing using genetic algorithms |
title_full_unstemmed | Network controllability solutions for computational drug repurposing using genetic algorithms |
title_short | Network controllability solutions for computational drug repurposing using genetic algorithms |
title_sort | network controllability solutions for computational drug repurposing using genetic algorithms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791995/ https://www.ncbi.nlm.nih.gov/pubmed/35082323 http://dx.doi.org/10.1038/s41598-022-05335-3 |
work_keys_str_mv | AT popescuvictorbogdan networkcontrollabilitysolutionsforcomputationaldrugrepurposingusinggeneticalgorithms AT kanhaiyakrishna networkcontrollabilitysolutionsforcomputationaldrugrepurposingusinggeneticalgorithms AT nastacdumitruiulian networkcontrollabilitysolutionsforcomputationaldrugrepurposingusinggeneticalgorithms AT czeizlereugen networkcontrollabilitysolutionsforcomputationaldrugrepurposingusinggeneticalgorithms AT petreion networkcontrollabilitysolutionsforcomputationaldrugrepurposingusinggeneticalgorithms |